In this Section
4296.0 Reaching Subgroups at Greatest Risk with New Medical Technologies: Learning from the Human Papillomavirus (HPV) Vaccine
Tuesday, November 9, 2010: 2:30 PM - 4:00 PM
This session, “Reaching Subgroups at Greatest Risk with New Medical Technologies: Learning from the Human Papillomavirus (HPV) Vaccine,” will use the HPV vaccine as a case study for examining factors that influence adoption of new medical technologies among underserved groups. We will review current surveillance data on awareness and use of the HPV vaccine across subgroups at greatest risk of cervical cancer, with a special emphasis on racial and ethnic minorities and the uninsured. The session will highlight factors influencing vaccine uptake, including interest, financing and access. HPV vaccine promotion and payment policies will be described.
Session Objectives: 1. Describe factors influencing awareness, access and adoption of new medical technologies. 2. Discuss policies that have the potential to prevent or reduce disparities in technology adoption. 3. Assess surveillance data needed for evaluation of disparities in technology uptake.
Rebecca Anhang, PhD
Helen I. Meissner, PhD
See individual abstracts for presenting author's disclosure statement and author's information.
Organized by: Medical Care
CE Credits: Medical (CME), Health Education (CHES), Nursing (CNE), Public Health (CPH)
See more of: Medical Care